| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.57▼ | 7.62▼ | 7.65▼ | 7.68▼ | 7.82▼ |
| MA10 | 7.59▼ | 7.70▼ | 7.74▼ | 7.88▼ | 7.87▼ |
| MA20 | 7.62▼ | 7.78▼ | 7.81▼ | 7.84▼ | 6.88▲ |
| MA50 | 7.71▼ | 7.75▼ | 7.84▼ | 7.72▼ | 6.45▲ |
| MA100 | 7.78▼ | 7.90▼ | 7.90▼ | 6.75▲ | 5.82▲ |
| MA200 | 7.83▼ | 7.89▼ | 8.08▼ | 6.65▲ | 7.70▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.032▼ | -0.028▼ | -0.071▼ | 0.075▲ |
| RSI | 36.030▼ | 27.358▼ | 35.659▼ | 43.979▼ | 54.476▲ |
| STOCH | 20.625 | 6.175▼ | 8.846▼ | 18.683▼ | 65.479 |
| WILL %R | -69.231 | -89.333▼ | -92.982▼ | -88.285▼ | -35.607 |
| CCI | -98.117 | -123.739▼ | -148.289▼ | -96.754 | 28.314 |
|
Friday, August 15, 2025 03:42 AM
Second Quarter 2025 Results Key Financial Results Revenue: US$3.69m (up by ...
|
|
Thursday, August 14, 2025 05:15 AM
Gained alignment with U.S. Food and Drug Administration (FDA) on the ongoing Phase 2 AQUAx2 randomized double-blind, placebo-controlled pivotal study in Grade 2/3 radiation-induced xerostomia (RIX) to ...
|
|
Thursday, March 13, 2025 12:55 PM
March 13, 2025 — 03:55 pm EDT Written by Quiver EarningsTracker for Quiver Quantitative -> ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/08/25 | 7.56 | 7.65 | 7.53 | 7.57 | 9,771 |
| 25/08/25 | 7.83 | 7.915 | 7.56 | 7.58 | 212,720 |
| 22/08/25 | 7.91 | 8.105 | 7.801 | 7.83 | 310,647 |
| 21/08/25 | 7.52 | 7.92 | 7.46 | 7.85 | 193,289 |
| 20/08/25 | 7.58 | 7.63 | 7.43 | 7.56 | 259,760 |
| 19/08/25 | 7.94 | 8.01 | 7.485 | 7.58 | 317,398 |
| 18/08/25 | 8.19 | 8.43 | 7.885 | 7.97 | 326,247 |
| 15/08/25 | 8.23 | 8.505 | 7.88 | 8.17 | 717,939 |
| 14/08/25 | 8.44 | 8.625 | 8.0387 | 8.33 | 420,404 |
| 13/08/25 | 8.15 | 8.49 | 8.06 | 8.34 | 423,601 |
|
|
||||
|
|
||||
|
|